Natural Killer Cell Therapeutics Market
1 Introduction to Research & Analysis Reports
1.1 Natural Killer (NK) Cell Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Natural Killer (NK) Cell Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Natural Killer (NK) Cell Therapeutics Overall Market Size
2.1 Global Natural Killer (NK) Cell Therapeutics Market Size: 2021 VS 2028
2.2 Global Natural Killer (NK) Cell Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Natural Killer (NK) Cell Therapeutics Players in Global Market
3.2 Top Global Natural Killer (NK) Cell Therapeutics Companies Ranked by Revenue
3.3 Global Natural Killer (NK) Cell Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Natural Killer (NK) Cell Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Natural Killer (NK) Cell Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Natural Killer (NK) Cell Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Natural Killer (NK) Cell Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Natural Killer (NK) Cell Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Natural Killer (NK) Cell Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Mogamulizumab
4.1.3 Lorvotuzumab Mertansine
4.1.4 Others
4.2 By Type - Global Natural Killer (NK) Cell Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Natural Killer (NK) Cell Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Natural Killer (NK) Cell Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Natural Killer (NK) Cell Therapeutics Market Size, 2021 & 2028
5.1.2 Cancer
5.1.3 Cardiovascular Diseases
5.1.4 Others
5.2 By Application - Global Natural Killer (NK) Cell Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Natural Killer (NK) Cell Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Natural Killer (NK) Cell Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Natural Killer (NK) Cell Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Natural Killer (NK) Cell Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Natural Killer (NK) Cell Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Natural Killer (NK) Cell Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Natural Killer (NK) Cell Therapeutics Revenue, 2017-2028
6.3.2 US Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.3.3 Canada Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.3.4 Mexico Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Natural Killer (NK) Cell Therapeutics Revenue, 2017-2028
6.4.2 Germany Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.4.3 France Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.4.4 U.K. Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.4.5 Italy Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.4.6 Russia Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.4.8 Benelux Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Natural Killer (NK) Cell Therapeutics Revenue, 2017-2028
6.5.2 China Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.5.3 Japan Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.5.4 South Korea Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.5.6 India Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Natural Killer (NK) Cell Therapeutics Revenue, 2017-2028
6.6.2 Brazil Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.6.3 Argentina Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue, 2017-2028
6.7.2 Turkey Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.7.3 Israel Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
6.7.5 UAE Natural Killer (NK) Cell Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Chipscreen Biosciences
7.1.1 Chipscreen Biosciences Corporate Summary
7.1.2 Chipscreen Biosciences Business Overview
7.1.3 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.1.4 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Chipscreen Biosciences Key News
7.2 Affimed NV
7.2.1 Affimed NV Corporate Summary
7.2.2 Affimed NV Business Overview
7.2.3 Affimed NV Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.2.4 Affimed NV Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Affimed NV Key News
7.3 Altor BioScience
7.3.1 Altor BioScience Corporate Summary
7.3.2 Altor BioScience Business Overview
7.3.3 Altor BioScience Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.3.4 Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Altor BioScience Key News
7.4 Innate Pharma
7.4.1 Innate Pharma Corporate Summary
7.4.2 Innate Pharma Business Overview
7.4.3 Innate Pharma Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.4.4 Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Innate Pharma Key News
7.5 Takeda
7.5.1 Takeda Corporate Summary
7.5.2 Takeda Business Overview
7.5.3 Takeda Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.5.4 Takeda Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Takeda Key News
7.6 Sorrento Therapeutics
7.6.1 Sorrento Therapeutics Corporate Summary
7.6.2 Sorrento Therapeutics Business Overview
7.6.3 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.6.4 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Sorrento Therapeutics Key News
7.7 NantKwest
7.7.1 NantKwest Corporate Summary
7.7.2 NantKwest Business Overview
7.7.3 NantKwest Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.7.4 NantKwest Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2017-2022)
7.7.5 NantKwest Key News
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Corporate Summary
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.8.4 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Bristol-Myers Squibb Key News
7.9 NKT
7.9.1 NKT Corporate Summary
7.9.2 NKT Business Overview
7.9.3 NKT Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.9.4 NKT Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2017-2022)
7.9.5 NKT Key News
7.10 Henry Ford Health Services
7.10.1 Henry Ford Health Services Corporate Summary
7.10.2 Henry Ford Health Services Business Overview
7.10.3 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Major Product Offerings
7.10.4 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue in Global Market (2017-2022)
7.10.5 Henry Ford Health Services Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Natural Killer (NK) Cell Therapeutics Market Opportunities & Trends in Global Market
Table 2. Natural Killer (NK) Cell Therapeutics Market Drivers in Global Market
Table 3. Natural Killer (NK) Cell Therapeutics Market Restraints in Global Market
Table 4. Key Players of Natural Killer (NK) Cell Therapeutics in Global Market
Table 5. Top Natural Killer (NK) Cell Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Natural Killer (NK) Cell Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Natural Killer (NK) Cell Therapeutics Product Type
Table 9. List of Global Tier 1 Natural Killer (NK) Cell Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Natural Killer (NK) Cell Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Natural Killer (NK) Cell Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Natural Killer (NK) Cell Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Natural Killer (NK) Cell Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Natural Killer (NK) Cell Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Chipscreen Biosciences Corporate Summary
Table 31. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Product Offerings
Table 32. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Affimed NV Corporate Summary
Table 34. Affimed NV Natural Killer (NK) Cell Therapeutics Product Offerings
Table 35. Affimed NV Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Altor BioScience Corporate Summary
Table 37. Altor BioScience Natural Killer (NK) Cell Therapeutics Product Offerings
Table 38. Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Innate Pharma Corporate Summary
Table 40. Innate Pharma Natural Killer (NK) Cell Therapeutics Product Offerings
Table 41. Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Takeda Corporate Summary
Table 43. Takeda Natural Killer (NK) Cell Therapeutics Product Offerings
Table 44. Takeda Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Sorrento Therapeutics Corporate Summary
Table 46. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Product Offerings
Table 47. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. NantKwest Corporate Summary
Table 49. NantKwest Natural Killer (NK) Cell Therapeutics Product Offerings
Table 50. NantKwest Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Bristol-Myers Squibb Corporate Summary
Table 52. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Product Offerings
Table 53. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. NKT Corporate Summary
Table 55. NKT Natural Killer (NK) Cell Therapeutics Product Offerings
Table 56. NKT Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Henry Ford Health Services Corporate Summary
Table 58. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Product Offerings
Table 59. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Natural Killer (NK) Cell Therapeutics Segment by Type in 2021
Figure 2. Natural Killer (NK) Cell Therapeutics Segment by Application in 2021
Figure 3. Global Natural Killer (NK) Cell Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Natural Killer (NK) Cell Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Natural Killer (NK) Cell Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Natural Killer (NK) Cell Therapeutics Revenue in 2021
Figure 8. By Type - Global Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Natural Killer (NK) Cell Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Affimed NV Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Takeda Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. NantKwest Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. NKT Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
